Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 160, Suchdauer: 1.09s

12 3 4 5 6 7 weiter »

1
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

von Pearson, Andrew D.J. ; Zwaan, C.Michel ; Kolb, E.Anders ; et al.

In European Journal of Cancer September 2020 136:116-129
- View full text via DOI
Merkliste

2
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

von Pearson, Andrew D.J. ; Rossig, Claudia ; Lesa, Giovanni ; et al.

In European Journal of Cancer March 2020 127:52-66
- View full text via DOI
Merkliste

3
Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis

von Stone, Richard M. ; Manley, Paul W. ; Larson, Richard A. ; et al.

In Blood Advances 27 February 2018 2(4):444-453
- View full text via DOI
Merkliste

4
Implementation of mechanism of action biology-driven early drug development for children with cancer

von Georger, B. ; Iannone, R. ; Jakacki, R. ; et al.

In European Journal of Cancer July 2016 62:124-131
- View full text via DOI
Merkliste

5
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

von Pearso, Andrew D. J. ; Rossig, Claudia ; Lesa, Giovanni ; et al.

0959-8049 ; European journal of cancer

Schlagworte: Human medicine
- View full text via BASE
Merkliste

6
Glivec® (Gleevec®, Imatinib, STI571) : A Targeted Therapy for Chronic Myelogenous Leukemia

von Buchdunger, Elisabeth ; Capdeville, Renaud ; Teicher, Beverly A., editor ; et al.

Protein Tyrosine Kinases : From Inhibitors to Useful Drugs. :145-160
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

7
Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors

von Savelieva, Marina ; Woo ; Schran, Horst ; et al.

European Journal of Clinical Pharmacology. June 2015 71(6):663-672
- Zum Volltext (via ReDI)
Merkliste

8
Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium

von Geoerger, Birgit ; Morland, Bruce ; Ndiaye, Anna ; et al.

In European Journal of Cancer 2009 45(13):2342-2351
- View full text via DOI
Merkliste

9
Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects

von Dutreix, Catherine ; Peng, Bin ; Mehring, Guenther ; et al.

Cancer Chemotherapy and Pharmacology. October 2004 54(4):290-294
- Zum Volltext (via ReDI)
Merkliste

10
Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules

von Nikolova, Zariana ; Peng, Bin ; Hubert, Martine ; et al.

Cancer Chemotherapy and Pharmacology. May 2004 53(5):433-438
- Zum Volltext (via ReDI)
Merkliste

11
Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

von Bolton ; Peng, Bin ; Hubert, Martine ; et al.

Cancer Chemotherapy and Pharmacology. February 2004 53(2):102-106
- Zum Volltext (via ReDI)
Merkliste

12
Factors associated with death in children with purpura fulminans: a French national prospective cohort study

von Madhi, Fouad ; Ouldali, Naim ; Levy, Corinne ; et al.

Critical Care. 25(1)
- Zum Volltext in PubMed Central
Merkliste

13
Development of a second-generation genetic linkage map for peach [Prunus persica (L.) Batsch] and characterization of morphological traits affecting flower and fruit

von Dirlewanger, E. ; Cosson, P. ; Boudehri, K. ; et al.

Tree Genetics & Genomes. December 2006 3(1):1-13
- Zum Volltext (via ReDI)
Merkliste

14
Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G‐CSF mutant (Ro 25‐8315) in healthy volunteers: Comparison with single and multiple daily doses of filgrastim

von van der Auwera, Phillippe ; Platzer, Erich ; Xu, Z.‐X. ; et al.

American Journal of Hematology ; volume 66, issue 4, page 245-251 ; ISSN 0361-8609 1096-8652
- View full text via BASE
Merkliste

15
Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study

von Champagne, Martin A. ; Capdeville, Renaud ; Krailo, Mark ; et al.

In Blood 1 November 2004 104(9):2655-2660
- View full text via DOI
Merkliste

16
Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia

von Sonneveld, Pieter ; Burnett, Alan ; Vossebeld, Paula ; et al.

Sonneveld, P, Burnett, A, Vossebeld, P, Ben-Am, M, Rosenkranz, G, Pfister, C, Verhoef, G, Dekker, A, Ossenkoppele, G, Ferrant, C, Yin, L, Gratwohl, A, Kovacsovics, T, Vellenga, E, Capdeville, R & Löwenberg, B 2000, 'Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia', Hematology Journal, vol. 1, no. 6, pp. 411-421. https://doi.org/10.1038/sj.thj.6200050

Schlagworte: Acute myeloid leukemia; Daunorubicin; Multidrug resistance; Reversal of resistance; Valspodar
- View full text via BASE
Merkliste

17
Imatinib: A targeted clinical drug development

von Capdeville, Renaud ; Silberman, Sandra

In Seminars in Hematology April 2003 40 Supplement 2:15-20
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

18
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

von Pearson, Andrew. D. J. ; Zwaan, C. Michel ; Kolb, E. Anders ; et al.

0959-8049 ; European journal of cancer

Schlagworte: Human medicine
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

19
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias

von Ottmann, Oliver G. ; Druker, Brian J. ; Sawyers, Charles L. ; et al.

In Blood 15 September 2002 100(6):1965-1971
- View full text via DOI
Merkliste

20
The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML

von O'Dwyer, Michael E. ; Mauro, Michael J. ; Kurilik, Gwen ; et al.

In Blood 1 September 2002 100(5):1628-1633
- View full text via DOI
Merkliste

21
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study: Presented in part at the 43rd Annual Meeting of The American Society of Hematology, Orlando, FL, December 11, 2001.

von Sawyers, Charles L. ; Hochhaus, Andreas ; Feldman, Eric ; et al.

In Blood 15 May 2002 99(10):3530-3539
- View full text via DOI
Merkliste

22
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

von Talpaz, Moshe ; Silver, Richard T. ; Druker, Brian J. ; et al.

In Blood 15 March 2002 99(6):1928-1937
- View full text via DOI
Merkliste

23
Imatinib: the first 3 years

von Capdeville, Renaud ; Silberman, Sandra ; Dimitrijevic, Sasa

In European Journal of Cancer 2002 38 Supplement 5:S77-S82
- View full text via DOI
Merkliste

24
Implementation of mechanism of action biology-driven early drug development for children with cancer

von Pearson, Andrew D. J. ; Herold, Ralf ; Rousseau, Raphael ; et al.

0959-8049 ; European journal of cancer

Schlagworte: Human medicine
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

25
A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancer

von Dumez, Herlinde ; Gall, Helen ; Capdeville, Renaud ; et al.

Anti-Cancer Drugs ; volume 18, issue 2, page 219-225 ; ISSN 0959-4973
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

12 3 4 5 6 7 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag